A future for prediction and treatment of Sjögren's disease-associated lymphomas

Lancet Rheumatol. 2024 Oct;6(10):e658-e660. doi: 10.1016/S2665-9913(24)00228-5. Epub 2024 Aug 22.

Authors

Suzanne Arends¹, Arjan Vissink², Frans G M Kroese¹, Gwenny M Verstappen¹, Hendrika Bootsma¹

Affiliations

¹ Department of Rheumatology and Clinical Immunology, University of Groningen and University Medical Center Groningen, 9700 RB Groningen, Netherlands.
² Department of Oral and Maxillofacial Surgery, University of Groningen and University Medical Center Groningen, 9700 RB Groningen, Netherlands. Electronic address: a.vissink@umcg.nl.

PMID: 39182504
DOI: 10.1016/S2665-9913(24)00228-5

No abstract available

MeSH terms

Forecasting
Humans
Lymphoma* / diagnosis
Lymphoma* / therapy
Sjogren's Syndrome* / complications
Sjogren's Syndrome* / diagnosis
Sjogren's Syndrome* / therapy